Literature DB >> 30456465

What's new in immunostimulating strategies in the ICU.

Peter Pickkers1,2, Tom van der Poll3.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30456465     DOI： 10.1007/s00134-018-5462-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  Combining Prognostic and Predictive Enrichment Strategies to Identify Children With Septic Shock Responsive to Corticosteroids.

Authors:  Hector R Wong; Sarah J Atkinson; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie C Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Shekhar S Raj; Shira Gertz; Christopher J Lindsell
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

3.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

Authors:  S M Opal; C J Fisher; J F Dhainaut; J L Vincent; R Brase; S F Lowry; J C Sadoff; G J Slotman; H Levy; R A Balk; M P Shelly; J P Pribble; J F LaBrecque; J Lookabaugh; H Donovan; H Dubin; R Baughman; J Norman; E DeMaria; K Matzel; E Abraham; M Seneff
Journal:  Crit Care Med       Date:  1997-07       Impact factor: 7.598

4.  Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.

Authors:  Christian Meisel; Joerg C Schefold; Rene Pschowski; Tycho Baumann; Katrin Hetzger; Jan Gregor; Steffen Weber-Carstens; Dietrich Hasper; Didier Keh; Heidrun Zuckermann; Petra Reinke; Hans-Dieter Volk
Journal:  Am J Respir Crit Care Med       Date:  2009-07-09       Impact factor: 21.405

5.  Decreased Monocyte HLA-DR Expression in Patients After Non-Shockable out-of-Hospital Cardiac Arrest.

Authors:  Fabienne Venet; Martin Cour; Julie Demaret; Guillaume Monneret; Laurent Argaud
Journal:  Shock       Date:  2016-07       Impact factor: 3.454

6.  Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.

Authors:  Bita Shakoory; Joseph A Carcillo; W Winn Chatham; Richard L Amdur; Huaqing Zhao; Charles A Dinarello; Randall Q Cron; Steven M Opal
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

7.  Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients.

Authors:  Kim Timmermans; Matthijs Kox; Michiel Vaneker; Maarten van den Berg; Aaron John; Arjan van Laarhoven; Hans van der Hoeven; Gert Jan Scheffer; Peter Pickkers
Journal:  Intensive Care Med       Date:  2016-02-24       Impact factor: 17.440

8.  Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study.

Authors:  Andrew Conway Morris; Deepankar Datta; Manu Shankar-Hari; Jacqueline Stephen; Christopher J Weir; Jillian Rennie; Jean Antonelli; Anthony Bateman; Noel Warner; Kevin Judge; Jim Keenan; Alice Wang; Tony Burpee; K Alun Brown; Sion M Lewis; Tracey Mare; Alistair I Roy; Gillian Hulme; Ian Dimmick; Adriano G Rossi; A John Simpson; Timothy S Walsh
Journal:  Intensive Care Med       Date:  2018-06-07       Impact factor: 17.440

9.  Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series.

Authors:  Corine E Delsing; Mark S Gresnigt; Jenneke Leentjens; Frank Preijers; Florence Allantaz Frager; Matthijs Kox; Guillaume Monneret; Fabienne Venet; Chantal P Bleeker-Rovers; Frank L van de Veerdonk; Peter Pickkers; Alexandre Pachot; Bart Jan Kullberg; Mihai G Netea
Journal:  BMC Infect Dis       Date:  2014-03-26       Impact factor: 3.090

10.  Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study.

Authors:  Emma E Davenport; Katie L Burnham; Jayachandran Radhakrishnan; Peter Humburg; Paula Hutton; Tara C Mills; Anna Rautanen; Anthony C Gordon; Christopher Garrard; Adrian V S Hill; Charles J Hinds; Julian C Knight
Journal:  Lancet Respir Med       Date:  2016-02-23       Impact factor: 102.642
View more
  3 in total

Review 1.  The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis.

Authors:  Mark E Nunnally; Ricard Ferrer; Greg S Martin; Ignacio Martin-Loeches; Flavia R Machado; Daniel De Backer; Craig M Coopersmith; Clifford S Deutschman
Journal:  Intensive Care Med Exp       Date:  2021-07-02

Review 2.  Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.

Authors:  D van Lier; M Kox; P Pickkers
Journal:  J Intern Med       Date:  2020-12-30       Impact factor: 8.989

3.  Immunity check should be performed for all patients with septic shock? Yes.

Authors:  Julien Textoris
Journal:  Intensive Care Med       Date:  2020-01-21       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.